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Abstract The C-terminal part of the third intracellular loop of 
the/3-adrenoceptor is capable of stimulating adenylate cyclase in 
the presence of phospholipid vesicles via the stimulatory guanine 
nucleotide binding protein (G,) [Palm et al. (1989) FEBS Lett. 
254, 89-93]. We have investigated the structure of synthetic pep- 
tides corresponding to residues 284-295 of the turkey erythrocyte 
adrenoceptor in micelles, trifluoroethanol and aqueous solution, 
by using 2D IH NMR and CD. In the presence of phospholipid 
micelles the peptides display a C-terminal a-helical region, 
whereas the N-terminal part was found to be highly flexible. 
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1. Introduction 
Protein-protein interactions play a pivotal role in transmem- 
brane signalling by G protein-coupled receptors. The ability of 
the receptor to bind to the intracellular G protein after extracel- 
lular stimulation and to set off the GDP/GTP exchange and 
GTPase activity is essential for the activation cascade. To un- 
derstand how the signal is transferred to, and recognized by, 
the corresponding G protein will require more information on 
the tertiary structure of the intracellular loops of the receptor. 
It was proposed that upon binding of the hormone to the 
extracellular site of the receptor, the intracellular loops adopt 
a conformation which favors their interaction with the mediat- 
ing G protein [1]. Alternatively it was suggested that agonist 
binding will expose prototypic amphiphilic co-helical structures 
at an intracellular site for specific interaction with G proteins 
[2,3]. If the functional properties of these sites can be repre- 
sented by peptides, those peptides hould also serve as a model 
for the structural features of the corresponding receptor e- 
gions. 
Peptides representing parts of the intracellular loops of the 
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fl-adrenergic receptor from turkey erythrocytes were synthe- 
sized. Their effects on hormonal stimulation of adenylate 
cyclase was measured in isolated membranes or by incubation 
of individual components of the fl-adrenergic adenylate cyclase 
system which were functionally reconstituted in phospholipid 
vesicles [4,5]. While most peptides only decouple hormonally 
stimulated adenylate cyclase by competing with the corre- 
sponding receptor sites, the peptide T284-295 with the sequence 
REHKALKTLGII, comprising the C-terminal part of the third 
intracellular loop and extending into transmembrane helix 6, 
was the first receptor-derived peptide that was able to stimulate 
adenylate cyclase in a G protein-dependent manner. Moreover, 
this peptide can replace stimulatory receptors, like the fl- 
adrenergic receptor, in partially reconstituted phospholipid 
vesicles containing only Gs and adenylate cyclase. We proposed 
that this peptide assumes the active conformation of the corre- 
sponding receptor egion. 
For a better understanding of the molecular basis of signal 
transduction it is therefore desirable to uncover structural fea- 
tures of peptides involved in receptor coupling. Circular di- 
chroism and NMR spectroscopy were used to monitor the 
native state and structural transitions of those peptides. 
2. Materials and methods 
2.1. Materials 
DIC and HOBT were obtained from Fluka, Nucleosil columns from 
Macherey & Nagel. Protected amino acid derivatives were purchased 
from Calbiochem-Novabiochem, myristoyl-lyso-PC from Sigma, and 
deuterated myristoyl-lyso-PC from Avanti Polar Lipids. TFE-d 3 was 
obtained from Cambridge Isotopes. 
2.2. Peptide synthesis and analytical procedure 
Peptides were synthesized aspeptide amides using a Tentagel RAM 
resin on a Zinsser Analytic SMPS 350 A peptide synthesizer. Solid- 
phase syntheses were performed with 9-fluorenylmethylcarbonyl (F- 
moc) for protection and with DIC and HOBT for activation chemistry. 
A mixture of TFA/anisole/ethanedithiol wasused for cleavage. The 
peptides were purified by reverse-phase HPLC on a Nucleosil 300-7 
C18 (20 x 250 mm) column using a H20/0.1% TFA-acetonitrile gradi- 
ent. The calculated mass of the sequences was confirmed by MALDI- 
TOF mass pectroscopy. 
2.3. Circular dichroism 
CD spectra were recorded on a Jobin Ivon CD6 spectrometer. Ellip- 
ticity is reported as mean residue molar ellipticity. For preparing 
micelles the lyso-PC-water mixture was homogenized using a vortex 
mixer. 
2.4. Nuclear magnetic resonance 
Different amounts of TFE-d3 or deuterated lyso-PC were added to 
peptide samples at pH 4.15 and 10% D20 in 5 mm sample tubes. NMR 
was performed on Bruker AM300 and AMX500 NMR spectrometers, 
operating at 300 MHz and 500 MHz proton frequency. In2D experi- 
ments [6,7], quadrature detection i F1 dimension was achieved analo- 
gous to the method of Redfield [8], using time proportional phase 
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increments (TPPI) [9]. The water signal was suppressed bya presatura- 
tion pulse, typically 2.5 s long. In addition, the water resonance was 
saturated during mixing in NOESY experiments [1 t~l 2]. COSY [13-15] 
ROESY [16,17] and TOCSY [18,19] experiments were performed ac- 
cording to the standard pulse schemes. Chemical shifts are expressed 
downfield to the methyl group of TSE 
3. Results 
3.1. Circular dichroism measurements 
The CD spectra of the peptides T284-294 and T284-295 were 
obtained in aqueous olution, TFE and in the presence of 
micelles. The spectra of both peptides never differed, when 
compared under the same experimental conditions. Therefore, 
only the spectra of T284-295 are presented. Fig. 1 shows the 
effect of 10 mM lyso-PC on the CD spectra of T284-295. The 
structure of the peptide changes from random chain (open 
diamonds), with its typical minimum at 199 rim, to a peptide 
with 50% a-helix (crosses), according to quantifications of
Greenfield and Fasman [20]. Fig. 2 demonstrates the results 
with various concentrations of TFE. An isodichroic point was 
observed at 203 nm, indicating that the interchange between 
a-helix and random chain in the presence of TFE can be de- 
scribed as a two state process [21,22]. At a concentration f 64% 
TFE 40% a-helix was detected, whereas at 95% TFE, 70% of 
the peptide shows an a-helical conformation with the typical 
minima t 207 and 223 nm. Hence, high concentrations of TFE 
are required to bring about a conformation of high a-helicity 
to this peptide. 
3.2. Nuclear magnetic resonance 
Both peptides T284-294 and T284-295 were first dissolved in 
90% TFE-d3. ROESY, NOESY, TOCSY and COSY experi- 
ments indicate an a-helical structure and made a resonance 
assignment possible which was used as basis for the resonance 
assignment in the presence of micelles. Measurements of the 
peptide T284-294 in aqueous olution revealed no structural 
features, a random chain has to be assumed. In the presence 
of 60 mM deuterated lyso-PC micelles NOESY and TOCSY 
experiments were performed on T284-294. Fig. 3 shows the 
resonances of the backbone amide protons and their assign- 
ments. The NOESY experiment reveals 5 cross peaks in the 
amide region that all were identified as sequential NH~-NH~+~ 
cross-peaks connecting neighbouring backbone amide protons 
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Fig. 1. CD spectra of T284-295 in the absence and presence of 10 mM 
lyso-PC micelles. The concentration f the peptide was  10 -4 M at pH 7 
and 23°C. 
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Fig. 2. CD spectra ofT284-295 in the presence ofTFE. Concentrations 
of TFE were 0% (open diamonds), 64% (filled diamonds) and 95% 
(dots). All other parameters are the same as indicated in Fig. 1. 
from the core of the peptide to those at the C-terminal end (Fig. 
4). In NOESY experiments magnetization is only transferred 
over short distances, roughly the intensity of the cross peak is 
proportional to l lr 6, with r being the distance [23]. Since the 
distances between eighbouring backbone amide protons in 
a-helices are small the observed NHi-NH~+, correlations indi- 
cate an a-helical structure [24]. 
4. Discuss ion 
Circular dichroism and high resolution proton NMR spec- 
troscopy have been shown to be sensitive techniques tomonitor 
structural properties and structural transitions of peptides in 
environments a different as polar solvent and phospholipid 
micelles. 
Low concentrations of TFE can induce an a-helical confor- 
mation in short peptides which were characterized by CD [21]. 
T284-294 and T284-295 reveal a rather low tendency to adopt 
an a-helical structure ven at high concentrations of TFE. Sim- 
ilar results were obtained in 10 mM lyso-PC which lead to 50% 
a-helix. In contrast to T284-295, the wasp venom mastoparan 
which directly interacts with G proteins shows a complete 
a-helix in the presence of 10 mM lyso-PC [25]. We propose 
from the CD spectra that the helical part of the receptor derived 
peptide T284-295 is probably associated with the phospholipid 
micelles, whereas the rest of the peptide is flexible like a random 
chain. 
2D 1H NMR spectroscopy makes it possible, however, to 
determine those parts of the peptide T284-294 which become 
highly structured upon binding to micelles. 2D experiments of
T284-294 reveal that one turn of an a-helix extending from 
Lys-290 to the C-terminal I1e-294 is formed in the presence of 
phospholipid micelles. There is also a close proximity between 
the backbone amide protons of Ala-288 and Leu-289, but the 
corresponding cross-peak of Leu-289 to Lys-290 is absent. This 
may indicate a smooth changeover f om the helix in the C- 
terminal part of the peptide to a random chain in the N-termi- 
nal part of the peptide. The results also show that the C- 
terminal I1e-295 can be omitted. Therefore, either peptide T284- 
294 or T284-295 can be used to elucidate the structure of 
T284-295 in the presence of phospholipid miceUes and it can 
be expected that the secondary structure asssignments of the 
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synthetic peptide match closely the properties of the corre- 
sponding receptor egion. 
The assignment of a C-terminal helix extending from residue 
290 to 295 of the peptide agrees favorably with the predicted 
extension of the sixth transmembrane h lix distal to residue 291 
[26]. From the assignment of Lys-290 to the helical part this 
residue can be considered either as an integral part of the 
membrane or as part of a cytoplasmic extension of the trans- 
membrane helix [2,27]. 
In contrast, the N-terminal part lacks defined structures 
within the limits of detection, which led us to assume that minor 
secondary structure constraints allow a high level of flexibility. 
In accordance with the flexibility of the peptide the same region 
in the receptor might easily switch from the inactive to the 
active state of the receptor or assume a complementary struc- 
ture to the presumed recognition site of the G protein by in- 
duced fit. However, it has to be kept in mind that the 'open end' 
of the small peptide might be more constrained in the corre- 
sponding receptor environment. 
The receptor-derived synthetic peptide and the liganded re- 
ceptor behave in a functionally analogous manner in activating 
Gs protein [4,5]. In addition, in this study structural similarities 
have been established. Therefore, we propose that this peptide 
serves as an appropriate model to describe the essential struc- 
tural and functional features of the corresponding receptor site. 
In the past, mastoparan was considered to be the prime 
example to model G protein-linked receptor coupling [28]. It 
was shown that mastoparan adopts almost exclusively a single 
conformation i phospholipid vesicles or when in fast exchange 
with Go protein [29,30]. In contrast to mastoparan, site-specific, 
receptor-derived peptides, including T284-294, seem to be en- 
dowed with discrete domains one of which is conformationally 
flexible. It is tempting to speculate that the receptor shifts from 
an unliganded, inactive to a liganded, active state by transloca- 
tion of the sixth transmembrane h lix concomitant with expo- 
sure of a hydrophobic helical fragment o the surface. This 
portion together with the flexible part could serve as a counter- 
part to the bipartite receptor recognition site on the G protein. 
The composite nature of this binding site is supported by the 
very recent report hat an ~2-adrenoceptor-derived peptide can 
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Fig. 3. NH region of a 500 MHz ~H NMR spectrum of T284-294 
(5 mM) in the presence of 60 mM deuterated lyso-PC at pH 4.15 and 
30°C. The backbone amide resonances as well as the ring protons of 
His-286 are indicated. 
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Fig. 4. NH-NH region of a 500 MHz NOESY spectrum of T284-294 
(5 mM) in the presence of 60 mM deuterated lyso-PC at pH 4.15 and 
30°C. The mixing time was 200 ms. The number located on one side 
of each cross peak labels the NH-NH correlation of the corresponding 
amino acid residues. 
specifically be cross-linked to both the ct- and fl-subunits of the 
corresponding G protein [31]. Mastoparan, on the contrary, 
can form only cross-links to the ~subunit [32], indicating that 
mastoparan is able to fulfill only one aspect of the structural 
requirements for G protein coupling. 
For the first time the conformational properties of a recep- 
tor-derived G protein-stimulating peptide were determined in 
the presence of phospholipids. This reveals a rather igid, mem- 
brane-associated conformation joined to an easily adjustable 
sequence, probably 'linked' to corresponding G proteins by its 
sequence. Interaction with the corresponding G protein would 
require nothing else than exposure of the 'peptide region' after 
receptor activation to the complementary G protein site for 
binding. 
More receptor-derived peptides have to be characterized to
extract the structural features required for receptor-specific 
interaction during coupling. 
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